Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang 10408, Republic of Korea.
Fluorescence Core Imaging Center, Department of Life Science, Ewha Womans University, Seoul 03760, Republic of Korea.
Int J Mol Sci. 2024 Oct 9;25(19):10825. doi: 10.3390/ijms251910825.
This review concerns nc886, a 101-nucleotide non-coding RNA (ncRNA). Because nc886 is transcribed by RNA polymerase III (Pol III) and contains a CpG island in its promoter region, its expression is regulated by several transcription factors and the DNA methylation status. These features drive nc886 expression in two opposing directions during tumorigenesis. The known function of nc886 is to bind to and modulate the activity of target proteins such as PKR, Dicer, and OAS1. By being differentially expressed during tumorigenesis and interacting with these proteins, nc886 plays a role in tumor surveillance, promotes or suppresses tumorigenesis, and influences the efficacy of cancer therapy. The multiple roles of nc886 have been well-documented in the literature. In this review, we have summarized this literature and critically discussed the roles and mechanisms of action of nc886 in various cancers.
本文综述了 nc886,一种 101 个核苷酸的非编码 RNA(ncRNA)。由于 nc886 由 RNA 聚合酶 III(Pol III)转录,并且其启动子区域含有 CpG 岛,其表达受到几种转录因子和 DNA 甲基化状态的调控。这些特征在肿瘤发生过程中驱使 nc886 以相反的方向表达。已知 nc886 的功能是与靶蛋白(如 PKR、Dicer 和 OAS1)结合并调节其活性。通过在肿瘤发生过程中差异表达并与这些蛋白相互作用,nc886 在肿瘤监测中发挥作用,促进或抑制肿瘤发生,并影响癌症治疗的疗效。nc886 的多种作用在文献中已有充分记载。在这篇综述中,我们总结了这些文献,并批判性地讨论了 nc886 在各种癌症中的作用和作用机制。